Literature DB >> 6849777

Contribution of the vagus to the haemodynamic responses following intravenous boluses of isoprenaline.

J M Arnold, D G McDevitt.   

Abstract

1 Eight healthy subjects (six male, two female, aged 18-21 years) received graded intravenous bolus injections of isoprenaline sulphate. Heart rate and intra-arterial blood pressure were continuously monitored PRE- and POST-atropine (0.04 mg/kg). 2 PRE-atropine, an increase in heart rate of 25 beats/min was produced by 2.15 +/- 0.53 micrograms of isoprenaline and was associated with a fall in mean, systolic and diastolic pressures (18.9 +/- 2.8, 17.7 +/- 3.4 and 20.4 +/- 2.3 mm Hg respectively). 3 POST-atropine, the heart rate dose response curve was shifted to the right so that the dose of isoprenaline which increased heart rate 25 beats/min PRE-atropine, produced a significantly smaller heart rate rise of 20.3 +/- 1.7 beats/min (P less than 0.001). This was associated with a shift of the blood pressure dose-response curves to the left, and larger falls in mean, systolic and diastolic pressures (30.9 +/- 2.8, 31.8 +/- 3.3, 30.1 +/- 3.3 mm Hg respectively; P less than 0.01). 4 It is concluded that there is a significant contribution from a reflex withdrawal of cardiac vagal tone, to the tachycardia produced by a bolus of isoprenaline.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6849777      PMCID: PMC1427796          DOI: 10.1111/j.1365-2125.1983.tb01525.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  7 in total

1.  Presynaptic muscarinic cholinergic receptors.

Authors:  V K Sharma; S P Banerjee
Journal:  Nature       Date:  1978-03-16       Impact factor: 49.962

Review 2.  The assessment of beta-adrenoceptor blocking drugs in man.

Authors:  D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1977-08       Impact factor: 4.335

3.  Selective blockade of adrenoceptive beta receptors in the heart.

Authors:  D Dunlop; R G Shanks
Journal:  Br J Pharmacol Chemother       Date:  1968-01

4.  Comparison of the effects of I.C.I. 50172 and propranolol on the cardiovascular responses to adrenaline, isoprenaline and exercise.

Authors:  I Brick; K J Hutchison; D G McDevitt; I C Roddie; R G Shanks
Journal:  Br J Pharmacol       Date:  1968-09       Impact factor: 8.739

5.  A standardized isoproterenol sensitivity test. The effects of sinus arrhythmia, atropine, and propranolol.

Authors:  C R Cleaveland; R E Rangno; D G Shand
Journal:  Arch Intern Med       Date:  1972-07

6.  Effect of atenolol, metoprolol, and propranolol on isoproterenol-induced tremor and tachycardia in normal subjects.

Authors:  E Perucca; H Pickles; A Richens
Journal:  Clin Pharmacol Ther       Date:  1981-04       Impact factor: 6.875

7.  Acetylcholine antagonism of the electrophysiological effects of isoproterenol on canine cardiac Purkinje fibers.

Authors:  J C Bailey; A M Watanabe; H R Besch; D A Lathrop
Journal:  Circ Res       Date:  1979-03       Impact factor: 17.367

  7 in total
  15 in total

1.  Comparison of hypokalaemic, electrocardiographic and haemodynamic responses to inhaled isoprenaline and salbutamol in young and elderly subjects.

Authors:  B J Lipworth; B F Tregaskis; D G McDevitt
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

2.  Cardiovascular and autonomic pharmacology of the macrolide antibiotic LY281389 in anesthetized beagles and in isolated smooth and cardiac muscles.

Authors:  W E Colbert; J A Turk; P D Williams; M K Buening
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

3.  Assessment of airways, tremor and chronotropic responses to inhaled salbutamol in the quantification of beta 2-adrenoceptor blockade.

Authors:  B J Lipworth; R A Brown; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1989-07       Impact factor: 4.335

4.  Racial differences in drug response: isoproterenol effects on heart rate in healthy males.

Authors:  D R Rutledge; L Cardozo; J D Steinberg
Journal:  Pharm Res       Date:  1989-02       Impact factor: 4.200

5.  Isoprenaline as an aid to the induction of catecholamine dependent supraventricular tachycardias during programmed stimulation.

Authors:  B Brembilla-Perrot; A Terrier de la Chaise; M Pichené; E Aliot; F Cherrier; C Pernot
Journal:  Br Heart J       Date:  1989-04

6.  Indirect blood pressure measurement during intravenous isoprenaline infusions.

Authors:  J M Arnold; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1985-01       Impact factor: 4.335

7.  Enhancement of physiological finger tremor by intravenous isoprenaline infusions in man: evaluation of its role in the assessment of beta-adrenoceptor antagonists.

Authors:  J M Arnold; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1984-08       Impact factor: 4.335

8.  Vagal activity is increased during intravenous isoprenaline infusion in man.

Authors:  J M Arnold; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1984-09       Impact factor: 4.335

9.  Beta-receptor responsiveness after desipramine treatment.

Authors:  R Pohl; G N Pandey; V K Yeragani; R Balon; J M Davis; R Berchou
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

10.  Beta-adrenergic receptor responsiveness to isoprenaline in humans: concentration-effect, as compared with dose-effect evaluation and influence of autonomic reflexes.

Authors:  A Martinsson; K Lindvall; A Melcher; P Hjemdahl
Journal:  Br J Clin Pharmacol       Date:  1989-07       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.